Best Dividend Stocks to Buy Now
SIGNAL9 screens a curated set of high-quality dividend payers — KO, PEP, JNJ, JPM, XOM, MCD, HD and more — and ranks them for entry today. See the current top dividend name, buy zone, target and stop, plus a verified track record.
Frequently asked questions
Are these the highest-yielding stocks?▼
No — highest yield often signals distress. SIGNAL9 ranks quality dividend payers by momentum, technical setup and multi-model consensus, so you're buying names with both an income floor and a live technical edge.
Which dividend stocks are covered?▼
The screen covers around 45 blue-chip dividend payers: consumer staples (KO, PEP, PG, MO), healthcare (JNJ, ABBV, PFE, MRK, LLY, UNH), energy (XOM, CVX), financials (JPM, BAC, WFC, BLK, GS, MS), REITs (O, PLD, AMT, SPG), utilities (SO, DUK, NEE, D), and industrials (CAT, MMM, HON, UPS, GE, IBM).
How often is this list updated?▼
Every 3 hours during market hours. The top dividend pick refreshes live whenever the bot finds a materially stronger setup — no waiting for a weekly newsletter.
Is this financial advice?▼
No. SIGNAL9 is an educational research terminal. Dividend yields, entry zones and stop-losses are informational only. Do your own due diligence before buying any income name.
How to read a dividend ranking
Dividend investing is often presented as the safe corner of the equity market. It is not — it is a different risk profile, not a smaller one. These are the checks worth running before you act on any yield-ranked list, including this one.
Yield is a ratio, and the denominator can collapse
Dividend yield is the annual payout divided by the share price. When a stock falls 40% and the board has not yet cut the dividend, the yield doubles — and the screen that ranks by yield puts the most damaged company at the top. This is why the highest-yielding name on any list deserves the most scepticism, not the least.
The practical filter is the payout ratio: dividends as a share of free cash flow. Below roughly 60% there is usually room to keep paying through a weak year. Above 90%, the company is funding the dividend out of goodwill or debt, and a cut is a matter of timing rather than probability.
Growth of the payout beats the level of the payout
A company yielding 2.5% and raising its dividend 10% a year overtakes a static 5% payer within roughly a decade, and it usually does so with a rising share price rather than a falling one. Look at the five-year dividend growth rate alongside the current yield; the combination tells you far more than either number alone.
Consistency matters too. A business that has raised its dividend through a recession has demonstrated something about its cash generation that no forward estimate can.
Interest rates set the competition
Dividend stocks compete with government bonds for the same income-seeking capital. When short-term rates are high, a 3% equity yield with equity risk attached looks considerably less attractive, and rate-sensitive sectors like utilities and REITs de-rate accordingly.
That relationship works in reverse as well, which is why income sectors often lead when the market begins to price rate cuts. Direction of rates is frequently a bigger driver of dividend-stock performance over a year than anything happening inside the individual companies.
What the SIGNAL9 ranking on this page actually measures
The table above is not a yield screen. It is the output of the same confluence model used across the terminal — trend structure, momentum, relative volume, news sentiment and risk-reward against a defined stop — applied to a curated universe of established dividend payers.
In other words, it answers 'which of these income names currently look technically well positioned', not 'which pays the most'. Combine it with the fundamental checks above rather than substituting one for the other. Every closed position from this model is listed publicly, wins and losses, on the bot track record page.
How these rankings are produced, what data feeds them and where the model fails is documented in our editorial policy and methodology. Nothing on this page is investment advice — see the risk disclaimer and contact us if you spot an error.